In New York City, mental illness is rife. Whether it comes from the high stress, fast pace, low green space, or financial problems, a recent study showed that nearly a tenth of all New Yorkers have experienced depression in the last year—about 540,000 people. And 62% of those people didn’t do anything to get help, according to the city’s Department of Health. “Behind these data are the life stories of more than half a million New Yorkers living with depression which underscores the importance of addressing barriers to care,” Dr. Herminia Palacio, the deputy mayor for health and human services, said in a statement.

COPE is the leading provider of ketamine infusions in New York City. Treatment is provided by our trained MDs in established, professional medical practices. Ketamine is emerging as an effective off-label treatment for Anxiety, Depression, OCD, PTSD and Chronic Pain. Read more about why you should consider ketamine treatment if you’ve tried traditional medications with no success. Ketamine treatment is helping to improve mental health in New York City.

Ketamine Infusions: Competitive Pricing, Flexible Scheduling, and Fewer Side Effects

Ketamine Infusions are a treatment many patients seek when they feel like they have tried everything else. It is giving people with treatment-resistant mental health conditions renewed hope. It’s also a popular treatment option in New York City, for these mental health conditions because it offers relief from the condition without some of the side effects including weight gain. COPE makes accessing ketamine treatment a safe and comfortable experience. Our pricing is competitive and appointments can be scheduled flexibly around your schedule.

Ketamine Infusion Therapy: How It Works

Ketamine is an innovative, cutting-edge medication for difficult to treat cases of depression, anxiety, and bipolar disorders, among others. We specialize in ketamine treatments for depression.  It was originally developed as an anesthetic, and approved by the FDA for such use in 1970.  Ketamine has since been discovered to have many other uses in medicine, including as a solution for treatment-resistant psychiatric illness.

The Treatment Process

To receive ketamine treatment, you must first be screened by one of our local Carnegie Hill, New York City psychiatric experts, to ensure that this is an appropriate treatment for you. Ketamine treatment isn’t for everyone, but it has had great success rates for many people.  Once approved and scheduled, you arrive at our office 15 minutes in advance to complete any remaining paperwork.  At your scheduled time, you will be escorted into a private room, with a comfortable, plush seat, and offered your choice of entertainment, including: cable television, Netflix, iPads and wifi, as well as coffee and water. We will do everything we can to make your treatment as comfortable and welcoming as possible.

Your ketamine treatment, which is administered via IV infusion, will last 40 minutes, and you will be asked to remain at the New York City COPE office for an additional hour for observation.  Once released, we ask that you have a friend or family member drive you home; alternatively, we are happy to help you arrange a taxi or Uber ride home.

Duration of Treatment

For the first two weeks of treatment, you will come in three times a week for an IV ketamine infusion (each being a 40 minute session, followed by a one-hour observation period.) You may find that you can then maintain remission of your illness on more traditional psychiatric medications.  Some patients, however, may need to come in for maintenance treatments, which will occur every week for four weeks. The sustained phase is once a month for six months (if necessary).

COPE offers ketamine or esketamine (Spravato) treatment in New York at our practice in Carnegie Hill, New York City, directed by Manish Zinzuvadia, MD.

Dr. Zinzuvadia received his MD from SUNY Downstate College of Medicine and completed his residency at New York Medical College in Valhalla, NY. He completed fellowship training in geriatric psychiatry at Weill Cornell Medical College.  He is on the voluntary faculty as a Clinical Instructor of Psychiatry with the Departments of Psychiatry and Geriatric Medicine where he teaches and supervises residents and fellows.

He has implemented programs using long acting antipsychotic injectables to decrease hospital readmission rates for treatment resistant schizophrenic patients in Brooklyn, NY.  He has a particular expertise in treating elderly patients both in the office setting and in-home visits.  He has been able to work with families to keep patients stable and at home instead of being placed into nursing facilities.

Dr. Zinzuvadia’s research interests include the use of long acting antipsychotics in treatment resistant schizophrenic patients, cognitive dysfunction and treatment resistant depression in older adults, novel psychopharmacological agents, and the use of technological interventions to increase access to quality psychiatric care while helping to predict the onset of psychiatric symptoms and assisting in outpatient treatment of mood disorders.